Login / Signup

The Efficacy of a Mix of Probiotics ( Limosilactobacillus reuteri LMG P-27481 and Lacticaseibacillus rhamnosus GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Clostridium difficile Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial.

Angela SavianoCarmine PetruzzielloClelia CancroNoemi MacerolaAnna PettiEugenia NuzzoAlessio MignecoVeronica Ojetti
Published in: Microorganisms (2024)
Our study showed, for the first time, the efficacy of these two specific probiotic strains in preventing antibiotic-associated diarrhea and clostridium difficile infection in adult hospitalized patients treated with antibiotic therapy. This result allows us to hypothesize that the use of specific probiotic strains during antibiotic therapy can prevent dysbiosis and subsequent antibiotic-associated diarrhea and clostridium difficile infection, thus resulting in both patient and economic health care benefits.
Keyphrases
  • healthcare
  • open label
  • escherichia coli
  • irritable bowel syndrome
  • clinical trial
  • stem cells
  • case report
  • radiation therapy
  • cell therapy
  • smoking cessation
  • rectal cancer
  • health information
  • affordable care act